Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment-Reference-Cited by-同舟云学术

Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment

Published:2016-08-15 Issue: Volume:7 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Kosa Peter,Ghazali Danish,Tanigawa Makoto,Barbour Chris,Cortese Irene,Kelley William,Snyder Blake,Ohayon Joan,Fenton Kaylan,Lehky Tanya,Wu Tianxia,Greenwood Mark,Nair Govind,Bielekova Bibiana

Funder

National Institutes of Health

Publisher

Frontiers Media SA

Subject

Neurology (clinical),Neurology

Reference40 articles.

1. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial;Wolinsky;Ann Neurol,2007

2. Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis;Altmann;Neurology,2009

3. Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis;Harrison;Neurology,2011

4. Optimizing the design of clinical trials where the outcome is a rate. Can estimating a baseline rate in a run-in period increase efficiency?;Frost;Stat Med,2008

5. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis;Smith;Neuroimage,2002

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-07

2. Clemastine fumarate accelerates accumulation of disability in progressive multiple sclerosis by enhancing pyroptosis;2024-04-10

3. Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms;Nature Communications;2022-12-12

4. Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients;Frontiers in Radiology;2022-11-11

5. The role of machine learning in developing non-magnetic resonance imaging based biomarkers for multiple sclerosis: a systematic review;BMC Medical Informatics and Decision Making;2022-09-15